Stock Price
1,268.50
Daily Change
-13.40 -1.05%
Monthly
-4.55%
Yearly
-15.39%
Q1 Forecast
1,289.06

Cipla reported INR74.61B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
aTyr Pharma USD 1.04M 544K Sep/2025
Brainstorm Cell Therapeutics USD 80K 26K Sep/2025
Capricor Therapeutics USD 59K 0 Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cipla INR 74.61B 19.39B Sep/2025
Dr.Reddys Laboratories INR 104.17B 3.61B Dec/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Immunic USD 1.5M 50K Jun/2024
Nektar Therapeutics USD 0 2.9M Sep/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sun Pharmaceuticals INR 157.04B 26.1B Sep/2025
TherapeuticsMD USD 2.91M 310K Jun/2024
UPL INR 175.45B 16.74B Sep/2025